Poteligeo
Analogs of Poteligeo
Find cheaper analogs and generic equivalents for Poteligeo.
Active Ingredient: mogamulizumab
Product Overview
About Poteligeo
Poteligeo is a medicine used to treat certain types of cancer.
What it is used for
Poteligeo is used to treat mycosis fungoides or Sezary syndrome.
How it is used
Poteligeo can only be obtained with a prescription and treatment should be supervised by a doctor who has experience in the treatment of cancer and in a place where equipment for resuscitation is available in case of rare and severe allergic reaction to the medicine. The medicine is given as an infusion (drip) into a vein lasting at least 1 hour. The recommended dose depends on the patient’s body weight and is given once a week for the first 4 weeks and then every 2 weeks. Patients should be monitored during and after the infusion for certain side effects related to the infusion. To reduce this risk, patients may be given other medicines such as an antipyretic (medicine that reduces fever) and an antihistamine (for treating allergic reactions) before or during treatment with Poteligeo. The doctor may interrupt or stop treatment, or reduce the dose, if the patient develops certain serious side effects.
How it works
The active substance in Poteligeo, mogamulizumab, is a monoclonal antibody (a type of protein) that has been designed to attach to a receptor (target) called CCR4. CCR4 is found on the surface of white blood cells, including the cancerous cells in mycosis fungoides or Sezary syndrome. By attaching to CCR4, mogamulizumab stimulates the body’s immune system to attack the cancer cells, helping to control the disease.
Active substance: mogamulizumab
Visitor ratings
Help others by rating how useful this product page is.
No ratings yet — be the first.
